Cargando…

Ascorbic Acid Has Superior Ex Vivo Antiproliferative, Cell Death-Inducing and Immunomodulatory Effects over IFN-α in HTLV-1-Associated Myelopathy

BACKGROUND: Clear therapeutic guidelines for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are missing due to the lack of randomized double-blind controlled clinical trials. Moderate yet similar clinical benefit has been demonstrated for IFN-α and high-dose ascorbic acid (AA) m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moens, Britta, Decanine, Daniele, Menezes, Soraya Maria, Khouri, Ricardo, Silva-Santos, Gilvanéia, Lopez, Giovanni, Alvarez, Carolina, Talledo, Michael, Gotuzzo, Eduardo, de Almeida Kruschewsky, Ramon, Galvão-Castro, Bernardo, Vandamme, Anne-Mieke, Van Weyenbergh, Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404116/ https://www.ncbi.nlm.nih.gov/pubmed/22848768 http://dx.doi.org/10.1371/journal.pntd.0001729

Ejemplares similares

Ascorbic acid has superior antiviral and antiproliferative effects over IFN-alpha in HAM/TSP PBMC ex vivo
por: Moens, Britta, et al.
Publicado: (2011)

CD80(+) and CD86(+) B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
por: Menezes, Soraya Maria, et al.
Publicado: (2014)

A Fas(hi) Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated Neuroinflammation
por: Menezes, Soraya Maria, et al.
Publicado: (2017)

Monocyte accumulation is an early event in HAM/TSP pathogenesis, while monocyte activation and IFN-regulated gene expression persist in chronic HAM/TSP
por: Menezes, Soraya Maria, et al.
Publicado: (2015)

Superior antiviral and antiproliferative activity of IFN-beta vs. IFN-alpha in primary ATL cells occurs downstream of STAT1 signaling
por: Khouri, Ricardo, et al.
Publicado: (2014)

Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines
por: Moens, Britta, et al.
Publicado: (2012)

CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis
por: Khouri, Ricardo, et al.
Publicado: (2011)

IFN-β induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-α in PBMCs of Adult T-cell Leukemia/Lymphoma patients
por: Dierckx, T, et al.
Publicado: (2017)

A selective defect in Fas-mediated apoptosis in HAM/TSP: An ex vivo, in vitro and in silico study
por: Menezes, Soraya Maria, et al.
Publicado: (2014)

B cell costimulatory molecules as potential biomarkers in HAM/TSP
por: Menezes, Soraya M, et al.
Publicado: (2011)

A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients
por: Khouri, Ricardo, et al.
Publicado: (2018)

HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers
por: Alvarez, Carolina, et al.
Publicado: (2014)

IL8 Gene Polymorphism SNP rs4073 analysis between HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis and HTLV-1 Carriers
por: Rúa, Jorge, et al.
Publicado: (2015)

Incidence of tropical spastic parapesis/ HTLV-1 associated myelopathy/ (TSP/HAM) in patients followed in a Reference center in Salvador, Brasil
por: Teixeira, Izabel Bou, et al.
Publicado: (2015)

Anti-CD3 monoclonal antibody as a possible therapeutic alternative in HAM/TSP
por: Van Weyenbergh, Johan, et al.
Publicado: (2014)

Decreased RORC expression and downstream signaling in HTLV‐1‐associated adult T‐cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?
por: Subramanian, Kritika, et al.
Publicado: (2018)

Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-β Response in HTLV-1-Associated Neuroinflammation
por: Leal, Fabio E., et al.
Publicado: (2018)

Differential miRNA expression profiles in Peruvian HTLV-1 carriers
por: Rosado, Jason, et al.
Publicado: (2014)

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Schwalb, Alvaro, et al.
Publicado: (2020)

Quality of life (QOL) and depression in HTLV-1 carriers
por: Galvão-Phileto, Ana V, et al.
Publicado: (2011)

KIR genes and adult T-cell leukemia/lymphoma in patients infected with HTLV-1
por: Melo, Omar, et al.
Publicado: (2015)

Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study
por: Martin, Fabiola, et al.
Publicado: (2015)

Development of HTLV-1 Database for data management and datamining HTLV-1 sequences
por: Araujo, Thessika H A, et al.
Publicado: (2011)

Proteomic profiles among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Temoche, Morayma, et al.
Publicado: (2014)

Differential expression in genes involved in the NF-κβ pathway among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Talledo, Michael, et al.
Publicado: (2014)

Impact of fractures and orthopedic surgeries in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis
por: Julca-Copello, Pablo, et al.
Publicado: (2020)

Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation
por: Hurtado-Guerrero, Isaac, et al.
Publicado: (2020)

Assessment of functional capacity and flexibility of patients infected with HTLV-1
por: Santos, Isabelle Rocha, et al.
Publicado: (2015)

Pattern mRNA expression similarities between ATL patients and patients coinfected with HTLV-I-Strongyolides stercoralis
por: Talledo, Michael, et al.
Publicado: (2011)

Absence of HTLV‐II Co‐infection in HTLV‐I‐associated Myelopathy Patients
por: Miyamoto, Kanji, et al.
Publicado: (1992)

A NKG2D Thr72Ala polymorphism is not associated with HAM/TSP and proviral load values in Peruvian HTLV-1 infected patients with HAM/TSP and asymptomatic carriers
por: Bernia, Cynthia, et al.
Publicado: (2015)

Expression of hbz mRNA promotes survival in HTLV-1-infected cells with high DNA damage
por: Flores, Karina, et al.
Publicado: (2011)

Treatment of patients with HTLV-1-associated myelopathy with methotrexate
por: Ahmed, S, et al.
Publicado: (2014)

SOD1 Plasma Level as a Biomarker for Therapeutic Failure in Cutaneous Leishmaniasis
por: Khouri, Ricardo, et al.
Publicado: (2014)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1-associated infective dermatitis and probable HTLV-1- associated myelopathy in an adolescent female
por: Steglich, Raquel Bisacotti, et al.
Publicado: (2015)

Proviral load does not discriminate patients with Human T-Cell Leukemia/Lymphoma (ATLL) from HTLV-1 carriers with a history of Strongyloidiasis
por: López, Giovanni, et al.
Publicado: (2011)

HTLV-1 associated myelopathy of rapid onset and progression following living-donor kidney transplant: Clinical description and initial response to empirical treatment
por: Gonzales, Liliana, et al.
Publicado: (2011)

Aquaporin-4 Antibodies Are Not Related to HTLV-1 Associated Myelopathy
por: von Glehn, Felipe, et al.
Publicado: (2012)

Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5vo7ojfp94up54r4jgtmlbq898